Even as the company continues to defend the safety of its flagship product, pharmaceutical giant Johnson & Johnson announced on Tuesday that it would discontinue selling its talc-based baby powder product in the U.S. Facing tens of thousands of lawsuits from...
Litigation Update: California Appeals Court Reinstates Thousands of Risperdal Cases Against Johnson & Johnson
On May 8, the California 2nd District Court of Appeals reinstated thousands of cases pending against drug manufacturer Johnson & Johnson involving the antipsychotic drug Risperdal. The March, 2017 lower court ruling in the Risperdal and Invega Products Liability...
Litigation Update: Zantac Leadership Is Selected
On Friday, May 8th, District Judge Robin Rosenberg, of the U.S. District Court for the Southern District of Florida, appointed 26 lawyers to a range of leadership positions to the Zantac MDL that was transferred to Florida last February. Initially, the Judge had...
Litigation Update: J&J Talc Trial Continue in Missouri and New Jersey
Talc manufacturer Johnson and Johnson recently found itself in courtrooms in both New Jersey and Missouri battling in cases filed by plaintiffs who claim that the company’s talc products contained asbestos and caused their ovarian cancers. Missouri On April 24, the...
Four Reasons for Mass Tort Law Firms to Engage an Outsourced Services Provider
Perhaps your law firm had been considering engaging a third-party services provider—and then the COVID-19 crisis hit. Many firms have furloughed or terminated staff, have teams working remotely, and are struggling to figure out how to make the new normal as efficient...
Litigation Update: Johnson & Johnson Files Motion for a New Punitive Damages Trial
In February, after a massive punitive damages verdict, Johnson and Johnson filed a motion seeking a new trial on the issue of the award as well as motions asking for judgment notwithstanding the verdict and remittitur. In its filings, J&J claimed that the...
Litigation Update: Zantac MDL Procedures Are Announced
On April 1, 2020, the FDA requested the recall of all ranitidine heartburn medication products (commonly known by the brand name Zantac) because of the risks posed by NDMA contamination in some samples tested. Last week, Judge Robin L. Rosenberg, who is presiding over...
Litigation Update: FDA Orders for an Immediate Removal of Zantac from the Market
On April 1st, the FDA announced a global halt of the heartburn medication ranitidine, sold under the brand name of Zantac. This follows an initial warning back in September 2019, when low levels of a toxic compound and probable human carcinogen, NDMA...
Litigation Update: Impact of Coronavirus on Court Closings
The novel coronavirus pandemic continues to impact courts across the country and force the postponements of several key jury trials: Missouri The Missouri Supreme Court has cancelled all in-person arguments for the month of April; nevertheless, the Missouri Eastern...
Litigation Update: Roundup Advertising Class Action Settled for $39.5 Million
On March 23, Bayer AG - on behalf of its Monsanto unit - agreed to pay $39.5 million to settle claims that it ran misleading ads for its controversial weed killer, Roundup. The lead plaintiff in the proposed class filed in the USDC for the Western District of...